Dearborn Partners’s Healthpeak Properties DOC Stock Holding History

Dearborn Partners’s Portfolio DOC Stock Details DOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-67,684	Closed	-$2.18M	–	247
2022 Q3	$2.18M	Buy	67,684 +11,110	+20%	+$293K	0.1%	78
2022 Q2	$1.67M	Buy	56,574 +51,244	+961%	+$1.55M	0.07%	88
2022 Q1	$288K	Sell	5,330 -115	-2%	-$3.87K	0.01%	219
2021 Q4	$496K	Buy	+5,445	New	+$188K	0.02%	171

Other funds holding DOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Resolution Capital Sydney, NSW, Australia $4.76B AUM 10.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dearborn Partners's DOC Position: Q4 2022 in Review

Dearborn Partners sold out of Healthpeak Properties (DOC) in Q4 2022, closing a stake of 67,684 shares — an estimated $2.18M sold.

Dearborn Partners first reported a position in DOC in Q4 2021 and held it in 4 quarters. The position peaked at $2.18M in Q3 2022. 613 funds tracked by Wall St. Rank hold DOC as of Q4 2022.

Dearborn Partners reported no remaining Healthpeak Properties position as of Q4 2022 after selling out during the quarter.
Dearborn Partners sold 67,684 Healthpeak Properties shares in Q4 2022, an estimated $2.18M.
Dearborn Partners first reported a position in Healthpeak Properties in Q4 2021 and held it in 4 quarters.
Dearborn Partners's Healthpeak Properties position peaked at $2.18M in Q3 2022.
613 funds tracked by Wall St. Rank held Healthpeak Properties as of Q4 2022.

Based on Dearborn Partners's 13F filing for Q4 2022, filed 2 Feb 2023.